GLP-1 vs Metformin for Weight Loss: What the Evidence Actually Shows

If you've been researching weight loss medications, you've probably come across both GLP-1 medications like semaglutide and metformin. Maybe your doctor mentioned one of them, or you've seen conflicting information online about which works better. The truth is, while both can play a role in weight management, they're quite different medications with different purposes—and understanding these differences can help you make the right choice for your health.

Let's look at what the research actually tells us about how these medications compare for weight loss, who they're designed for, and what you can realistically expect from each.

What Metformin Is and How It Works

Metformin has been around since the 1950s and is primarily a diabetes medication. It's the first-line treatment for type 2 diabetes, and doctors prescribe it to help lower blood sugar levels and improve how your body responds to insulin.

The weight loss effect of metformin is generally considered a secondary benefit rather than its main purpose. It works by reducing how much glucose your liver produces, improving insulin sensitivity in your muscles and fat tissue, and possibly affecting appetite signals in your gut. The result? Some people lose a modest amount of weight while taking it, though that's not why it was originally designed.

Metformin is available as a generic medication, which makes it quite affordable—often just a few dollars per month with insurance. It's been studied extensively for decades, so we know a lot about its safety profile and long-term effects.

What GLP-1 Medications Are and How They Work

GLP-1 receptor agonists—medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)—are a newer class of medications. They mimic a natural hormone in your body called glucagon-like peptide-1 that gets released after you eat.

These medications work through several mechanisms. They slow down how quickly food leaves your stomach, which helps you feel full longer. They work on appetite centers in your brain to reduce hunger and food cravings. They also help your pancreas release insulin more effectively when your blood sugar rises and tell your liver to produce less glucose.

While GLP-1 medications were initially developed for type 2 diabetes, their significant weight loss effects led to specific formulations being FDA-approved specifically for chronic weight management in people with obesity or overweight with related health conditions.

Comparing Weight Loss Results: What the Studies Show

This is where the differences become really clear. The amount of weight loss people experience with these two medications is substantially different.

With metformin, clinical studies show an average weight loss of about 4-7 pounds over six months to a year. Some people lose a bit more, some lose less, and some don't lose weight at all. The weight loss tends to plateau fairly quickly, and it's modest compared to other interventions.

With GLP-1 medications, the results are much more significant. In clinical trials, people taking semaglutide (at the higher doses used for weight loss) lost an average of 15-20% of their body weight over 68 weeks—that's typically 30-40 pounds or more for many people. Tirzepatide, which also targets a second hormone called GIP, showed even more impressive results in some studies, with average weight loss around 20-25% of body weight.

That's not a small difference. We're talking about 5-10 pounds with metformin versus 30-50 pounds with GLP-1 medications for many people. The magnitude of effect is simply on a different scale.

Who Each Medication Is Really Designed For

Understanding who these medications are intended for is just as important as knowing how much weight they help you lose.

Metformin is FDA-approved for type 2 diabetes and for diabetes prevention in people with prediabetes. While doctors sometimes prescribe it off-label for weight management, especially in people with insulin resistance or PCOS, weight loss isn't its primary indication. If you have type 2 diabetes or prediabetes, metformin is often a sensible first step that can help with both blood sugar control and modest weight management.

GLP-1 medications have two different FDA approvals depending on the specific drug and dose. They're approved for type 2 diabetes at certain doses, and they're also specifically approved for chronic weight management in adults with obesity (BMI of 30 or higher) or overweight (BMI of 27 or higher) with at least one weight-related health condition like high blood pressure, high cholesterol, or type 2 diabetes.

In other words, if your primary goal is significant weight loss and you meet the criteria, GLP-1 medications are actually designed for that purpose. Metformin is designed for something else—blood sugar control—and happens to cause some weight loss as a side effect.

Side Effects and Tolerability

Both medications come with potential side effects, though they tend to be different types.

Metformin's most common side effects are gastrointestinal—diarrhea, nausea, stomach upset, and sometimes a metallic taste. These symptoms are usually most prominent when you first start the medication and often improve over time. Taking the extended-release version and starting with a low dose can help. A small percentage of people develop vitamin B12 deficiency with long-term use, which is why doctors sometimes recommend monitoring B12 levels.

GLP-1 medications also commonly cause gastrointestinal side effects, particularly nausea, which affects many people especially when starting or increasing doses. Some people also experience vomiting, diarrhea, constipation, or decreased appetite (which is partly how they work). These side effects are usually temporary and improve as your body adjusts. Starting at a low dose and increasing gradually helps minimize these effects. More rarely, GLP-1s carry warnings about pancreatitis and gallbladder problems.

The good news is that both medications have been studied extensively, and serious side effects are relatively uncommon with proper medical supervision.

For Women

Women with PCOS often have insulin resistance even without diabetes, and metformin has been used for years to help with this condition. It may help regulate periods and improve fertility in women with PCOS, which is an added benefit beyond the modest weight loss. GLP-1 medications can be highly effective for weight loss in women with PCOS as well, and the more significant weight reduction may have additional metabolic benefits. If you're of childbearing age, it's important to know that both weight loss and improved insulin sensitivity can affect fertility, so reliable contraception is important unless you're actively trying to conceive. You should stop GLP-1 medications at least two months before trying to get pregnant.

For Men

Men often respond slightly more quickly to metformin for blood sugar control, though the modest weight loss effects are similar to women. With GLP-1 medications, men frequently see robust weight loss results similar to women, though body composition changes may differ—men often see more reduction in visceral fat around organs, which is particularly beneficial for metabolic health. Men are sometimes more hesitant to seek help for weight management, but both medication classes have been shown to significantly improve cardiovascular risk factors like blood pressure and cholesterol that particularly affect men as they age.

Can You Take Both Together?

Yes, actually. Metformin and GLP-1 medications work through different mechanisms, so they can be combined safely under medical supervision. In fact, many people with type 2 diabetes take both medications together—metformin for its insulin-sensitizing effects and a GLP-1 for both blood sugar control and weight management.

Some doctors prescribe metformin alongside a GLP-1 medication for people without diabetes but with insulin resistance, as the combination may provide complementary metabolic benefits. This is something to discuss with your healthcare provider based on your specific health situation.

Cost and Access Considerations

This is where things get practical. Metformin is available as an inexpensive generic, often costing less than $10 per month without insurance and sometimes just a few dollars with insurance. It's widely accessible and easy to get prescribed.

Brand-name GLP-1 medications can be expensive—often $1,000 or more per month without insurance. Insurance coverage varies widely, with many plans covering GLP-1s for diabetes but not for weight loss alone. However, compounded versions of semaglutide and tirzepatide have become available through telehealth services at much more accessible price points, typically in the $99-$300 per month range, making this option more realistic for many people.

Which One Is Right for You?

The answer depends on your specific situation and goals.

Metformin might be the right choice if you have type 2 diabetes or prediabetes, you're looking for a medication that primarily addresses insulin resistance, you want an inexpensive and well-established option, or you're looking for a modest assist with weight management alongside lifestyle changes.

A GLP-1 medication might be more appropriate if you have a significant amount of weight to lose (generally 30 pounds or more), you've struggled with appetite control and cravings, you have obesity or overweight with related health conditions, or you want a medication specifically designed and proven for substantial weight loss.

For some people, the answer might be both—starting with metformin for blood sugar management and adding a GLP-1 later for more significant weight loss, or using them together from the start under medical guidance.

From the Ozari Care Team

We see many patients who've tried metformin first with modest results and then transition to GLP-1 therapy when they need more significant weight loss support. Both medications can play valuable roles, but being honest about your weight loss goals from the beginning helps us create the most effective treatment plan. If you need to lose substantial weight, starting with a medication actually designed for that purpose—like a GLP-1—often makes more sense than hoping a diabetes medication will get you there.

The Bottom Line

While both metformin and GLP-1 medications can support weight loss and improve metabolic health, they're fundamentally different medications with different purposes and very different levels of weight loss effectiveness. Metformin is excellent for what it's designed to do—manage blood sugar and insulin resistance—with modest weight loss as a bonus. GLP-1 medications are specifically designed to produce significant weight loss and have clinical evidence showing they can help people lose 15-25% of their body weight.

The best choice depends on your health profile, your weight loss goals, what other conditions you're managing, and what you can access and afford. Both medications work best alongside healthy eating and regular physical activity, and both require medical supervision to use safely.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team — licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 24, 2026